Real-time enrollment status for this pancreatic cancer clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:58 PM UTC
| NCT Number | NCT07252232 |
| Recruiting Status | Recruiting |
| Condition | Pancreatic Cancer |
| Phase | PHASE3 |
| Target Enrollment | 500 participants |
| Active Locations | 43 sites in the US |
| Sponsor | Revolution Medicines, Inc. |
| Last Updated on CT.gov | September 23, 2026 (2 weeks ago) |
As of October 12, 2026: Clinical trial NCT07252232 is currently recruiting participants. This phase3 study for pancreatic cancer is actively seeking new participants at 43 locations across the United States. The study is sponsored by Revolution Medicines, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07252232 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 43 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07252232 was last updated 2 weeks ago (September 23, 2026). HelloStudys verifies this status automatically.